OrganoClick AB (publ) reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was SEK 41.03 million compared to SEK 38.53 million a year ago. Net loss was SEK 2.67 million compared to SEK 8.81 million a year ago. Basic loss per share from continuing operations was SEK 0.03 compared to SEK 0.09 a year ago.
For the six months, sales was SEK 84.51 million compared to SEK 71.16 million a year ago. Net loss was SEK 3.67 million compared to SEK 14.71 million a year ago. Basic loss per share from continuing operations was SEK 0.04 compared to SEK 0.15 a year ago.